Most not too long ago, it has been identified that conolidine and the above derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to some big range of endogenous opioids. Contrary to most opioid receptors, this receptor functions as being a scavenger and will not